| 
MechanismEGFR T790M inhibitors [+1]    | 
 | 
 | 
 | 
Inactive Indication-  | 
Drug Highest PhasePreclinical  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
 | 
MechanismADRM1 inhibitors   | 
Active Org.-  | 
 | 
Active Indication-  | 
 | 
Drug Highest PhasePending  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
100 Clinical Results associated with Selleck Chemicals LLC
0  Patents (Medical) associated with Selleck Chemicals LLC
100 Deals associated with Selleck Chemicals LLC
100 Translational Medicine associated with Selleck Chemicals LLC